Actively Recruiting
Utility of PCD Diagnostics to Improve Clinical Care
Led by Vanderbilt University Medical Center · Updated on 2025-07-01
200
Participants Needed
1
Research Sites
574 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
CONDITIONS
Official Title
Utility of PCD Diagnostics to Improve Clinical Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Referred to center for PCD diagnosis considerations
- Ability to perform study procedures
- Age greater than 2 years of age
You will not qualify if you...
- Age less than 2 years of age
- Inability to perform informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vanderbilt Children's hospital
Nashville, Tennessee, United States, 37232
Actively Recruiting
Research Team
M
Michael O'Connor, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here